FAST vs TERN · P/E 43, rev $7.55B vs $6.12B cap
Fastenal Company (FAST) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. TERN currently screens at market cap $6.12B.
Not investment advice. Open the FAST and TERN stock pages for the full models.
Not investment advice.